Sotac Pharmaceuticals bulk deals
NSE: SOTACPharmaceuticals & Biotechnology
Sotac Pharmaceuticals Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 2023 · Issue price ₹111
Last close ₹101.30up ₹4.80 (4.97%)
Share price at the NSE close on 28 Oct 2026. Previous close ₹96.50.
28 Oct: open ₹101.25, high ₹101.30, low ₹101.25
52-week range of traded prices to 28 Oct 2026
₹86.00Low, 31 Jul 2026₹139.65High, 28 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹112 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 19.41
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.90
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.20%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.58
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,400100.0% delivered
Sotac Pharmaceuticals bulk deals
Last 12 months, since 29 Oct 2025: 2 bulk deals, ₹1.88 Cr bought and ₹2.10 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Friday 13 Mar 20262 firms · ₹1.88 Cr bought · ₹2.10 Cr soldNet sold ₹0.21 Cr
- SoldSAMBHAVNATH INVESTMENTS AND FINANCES PRIVATE LIMITEDSold 1,89,600 at ₹110.551.72% of the company₹2.10 Cr
- BoughtADITYA ENTERPRISEBought 1,70,400 at ₹110.551.54% of the company₹1.88 Cr
Thursday 20 Mar 20252 firms · ₹2.20 Cr bought · ₹2.20 Cr soldNet nil
- BoughtCRAFT EMERGING MARKET FUND PCC- ELITE CAPITAL FUNDBought 1,83,600 at ₹120.001.66% of the company₹2.20 Cr
- SoldGOENKA BUSINESS & FINANCE LIMITEDSold 1,83,600 at ₹120.001.66% of the company₹2.20 Cr
Monday 10 Mar 20252 firms · ₹1.70 Cr bought · ₹1.70 Cr soldNet nil
- BoughtCRAFT EMERGING MARKET FUND PCC- ELITE CAPITAL FUNDBought 1,81,200 at ₹93.581.64% of the company₹1.70 Cr
- SoldGOENKA BUSINESS & FINANCE LIMITEDSold 1,81,200 at ₹93.581.64% of the company₹1.70 Cr
Tuesday 4 Mar 20252 firms · ₹1.58 Cr bought · ₹1.58 Cr soldNet nil
- BoughtCRAFT EMERGING MARKET FUND PCC- ELITE CAPITAL FUNDBought 1,53,600 at ₹102.801.39% of the company₹1.58 Cr
- SoldSAMBHAVNATH INVESTMENTS AND FINANCES PRIVATE LIMITEDSold 1,53,600 at ₹102.801.39% of the company₹1.58 Cr
Thursday 2 Jan 20251 firm · ₹0 bought · ₹1.16 Cr soldNet sold ₹1.16 Cr
- SoldSANDHYA SINGH GAHLAUTSold 99,600 at ₹116.300.90% of the company₹1.16 Cr
Thursday 22 Feb 20241 firm · ₹0.98 Cr bought · ₹0 soldNet bought ₹0.98 Cr
- BoughtNAV CAPITAL VCC - NAV CAPITAL EMERGING STAR FUNDBought 72,000 at ₹135.420.65% of the company₹0.98 Cr
Wednesday 21 Feb 20242 firms · ₹0.97 Cr bought · ₹0.94 Cr soldNet bought ₹0.03 Cr
- BoughtNAV CAPITAL VCC - NAV CAPITAL EMERGING STAR FUNDBought 73,200 at ₹132.160.66% of the company₹0.97 Cr
- SoldSUNFLOWER BROKING PRIVATE LIMITEDSold 70,800 at ₹132.180.64% of the company₹0.94 Cr
Friday 12 Jan 20241 firm · ₹1.23 Cr bought · ₹0 soldNet bought ₹1.23 Cr
- BoughtSANDHYASINGH ANUPAMSINGH GAHLOUTBought 1,05,600 at ₹116.590.96% of the company₹1.23 Cr
Monday 9 Oct 20232 firms · ₹1.12 Cr bought · ₹1.10 Cr soldNet bought ₹0.01 Cr
- BoughtSAMBHAVNATH INVESTMENTS AND FINANCES PRIVATE LIMITEDBought 92,400 at ₹120.990.84% of the company₹1.12 Cr
- SoldAG DYNAMIC FUNDS LIMITEDSold 91,200 at ₹121.000.83% of the company₹1.10 Cr
Tuesday 5 Sep 20231 firm · ₹0 bought · ₹1.57 Cr soldNet sold ₹1.57 Cr
- SoldNAV CAPITAL VCC - NAV CAPITAL EMERGING STAR FUNDSold 1,26,000 at ₹124.241.14% of the company₹1.57 Cr
Thursday 10 Aug 20232 firms · ₹0.99 Cr bought · ₹0.99 Cr soldNet nil
- BoughtAXITA EXPORTS PRIVATE LIMITEDBought 81,600 at ₹121.630.74% of the company₹0.99 Cr
- SoldSAMBHAVNATH INVESTMENTS AND FINANCES PRIVATE LIMITEDSold 81,600 at ₹121.630.74% of the company₹0.99 Cr
Monday 31 Jul 20232 firms · ₹0.82 Cr bought · ₹1.25 Cr soldNet sold ₹0.44 Cr
- SoldSUNFLOWER BROKING PRIVATE LIMITEDSold 1,06,800 at ₹117.420.97% of the company₹1.25 Cr
- BoughtV JOSHI IMPEX PRIVATE LIMITEDBought 69,600 at ₹117.500.63% of the company₹0.82 Cr
Monday 17 Jul 20232 firms · ₹2.12 Cr bought · ₹2.12 Cr soldNet nil
- SoldFORBES EMFSold 1,81,200 at ₹117.001.64% of the company₹2.12 Cr
- BoughtMINERVA VENTURES FUNDBought 1,81,200 at ₹117.001.64% of the company₹2.12 Cr
Friday 12 May 20232 firms · ₹0.99 Cr bought · ₹1.08 Cr soldNet sold ₹0.09 Cr
- SoldAG DYNAMIC FUNDS LIMITEDSold 90,000 at ₹119.510.81% of the company₹1.08 Cr
- BoughtNAV CAPITAL VCC - NAV CAPITAL EMERGING STAR FUNDBought 82,800 at ₹119.500.75% of the company₹0.99 Cr
Wednesday 19 Apr 20232 firms · ₹2.09 Cr bought · ₹2.00 Cr soldNet bought ₹0.08 Cr
- BoughtSAMBHAVNATH INVESTMENTS AND FINANCES PRIVATE LIMITEDBought 1,80,000 at ₹115.95₹2.09 Cr
- SoldGOENKA BUSINESS AND FINANCE LIMITEDSold 1,72,800 at ₹116.00₹2.00 Cr
Monday 17 Apr 20233 firms · ₹2.72 Cr bought · ₹3.05 Cr soldNet sold ₹0.34 Cr
- BoughtNAV CAPITAL VCC - NAV CAPITAL EMERGING STAR FUNDBought 2,36,400 at ₹115.00₹2.72 Cr
- SoldWHITE FIELDS INVESTMENTS FUND SC SPSold 1,45,200 at ₹115.27₹1.67 Cr
- SoldAG DYNAMIC FUNDS LIMITEDSold 1,20,000 at ₹115.00₹1.38 Cr
Thursday 13 Apr 20235 firms · ₹8.72 Cr bought · ₹3.68 Cr soldNet bought ₹5.04 Cr
- BoughtGOENKA BUSINESS AND FINANCE LIMITEDBought 5,68,800 at ₹119.62₹6.80 Cr
- SoldWHITE FIELDS INVESTMENTS FUND SC SPSold 1,54,800 at ₹120.75₹1.87 Cr
- SoldAG DYNAMIC FUNDS LIMITEDSold 1,50,000 at ₹120.75₹1.81 Cr
- BoughtWALPAR NUTRITIONS LIMITEDBought 1,06,800 at ₹115.00₹1.23 Cr
- BoughtAIRAN LIMITEDBought 60,000 at ₹115.00₹0.69 Cr
A bulk deal is one client trading more than half a per cent of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 29 deals on record since listing on 13 Apr 2023.